Middle East Pharmacy Manufacturing and Biotech Industries Set to Boom as International Companies Target the Region

The Middle East market for pharmaceutical manufacturing and biotechnology, already valued at over $28 billion and with annual growth in double digits, looks set for even stronger growth as some of the world’s major players eye the regional market, according to the organizers of the region’s premier industry event – Pharmaceutical Manufacturing and Biotechnology Middle East (PABME).

Back to news